Status:
COMPLETED
The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50
Lead Sponsor:
Inova Health Care Services
Conditions:
Colorectal Cancer
Eligibility:
All Genders
35-50 years
Brief Summary
The purpose of this study is to determine the frequency of colorectal cancer in male and female endurance athletes between the ages of 35 and 50.
Eligibility Criteria
Inclusion
- Adult males and females 35-50 years of age
- Male and female self-reported endurance athletes, defined by at least one of the following:
- Run at least two races of 50 miles or more
- Run 5 races of 26.2 miles or more
- Ability to complete testing in the protocol and make study visits
- Able and willing to consent to protocol
Exclusion
- Known or suspected history of inflammatory bowel disease, familial adenomatous polyposis (FAP), or Lynch Syndrome
- Concomitant illness that would prevent adequate patient assessment or in the investigators' opinion pose an added risk for study participants.
- Anticipated poor compliance
- Prisoners or subjects who are involuntarily incarcerated
- Persons with decisional incapacity/cognitive impairment
- Any history or evidence of severe illness or any other condition that would make the patient, in the opinion of the investigator unsuitable for the study
- Subject is involved with a worker's compensation, personal injury, or other legal matters related to their health
- Subject is enrolled in a separate interventional clinical trial
Key Trial Info
Start Date :
October 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 22 2025
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT05419531
Start Date
October 18 2022
End Date
October 22 2025
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inova Schar Cancer Institute
Fairfax, Virginia, United States, 22031